Literature DB >> 33245993

Sirtuins' control of autophagy and mitophagy in cancer.

Michele Aventaggiato1, Enza Vernucci2, Federica Barreca1, Matteo A Russo3, Marco Tafani4.   

Abstract

Mammalian cells use a specialized and complex machinery for the removal of altered proteins or dysfunctional organelles. Such machinery is part of a mechanism called autophagy. Moreover, when autophagy is specifically employed for the removal of dysfunctional mitochondria, it is called mitophagy. Autophagy and mitophagy have important physiological implications and roles associated with cellular differentiation, resistance to stresses such as starvation, metabolic control and adaptation to the changing microenvironment. Unfortunately, transformed cancer cells often exploit autophagy and mitophagy for sustaining their metabolic reprogramming and growth to a point that autophagy and mitophagy are recognized as promising targets for ongoing and future antitumoral therapies. Sirtuins are NAD+ dependent deacylases with a fundamental role in sensing and modulating cellular response to external stresses such as nutrients availability and therefore involved in aging, oxidative stress control, inflammation, differentiation and cancer. It is clear, therefore, that autophagy, mitophagy and sirtuins share many common aspects to a point that, recently, sirtuins have been linked to the control of autophagy and mitophagy. In the context of cancer, such a control is obtained by modulating transcription of autophagy and mitophagy genes, by post translational modification of proteins belonging to the autophagy and mitophagy machinery, by controlling ROS production or major metabolic pathways such as Krebs cycle or glutamine metabolism. The present review details current knowledge on the role of sirtuins, autophagy and mitophagy in cancer to then proceed to discuss how sirtuins can control autophagy and mitophagy in cancer cells. Finally, we discuss sirtuins role in the context of tumor progression and metastasis indicating glutamine metabolism as an example of how a concerted activation and/or inhibition of sirtuins in cancer cells can control autophagy and mitophagy by impinging on the metabolism of this fundamental amino acid.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Cancer; Cancer stem cells; Glutamine metabolism; Mitophagy; Sirtuins

Mesh:

Substances:

Year:  2020        PMID: 33245993     DOI: 10.1016/j.pharmthera.2020.107748

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  17 in total

1.  Huoxue Qianyang Qutan Recipe Protects against Early Renal Damage Induced by Obesity-Related Hypertension via the SIRT1/NF-κB/IL-6 Pathway: Integrating Network Pharmacology and Experimental Validation-Based Strategy.

Authors:  Mingzhu Wang; Jianhua Li; Mingtai Gui; Bo Lu; Lei Yao; Xunjie Zhou; Moyi Shi; Liang Hu; Deyu Fu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

2.  Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy.

Authors:  Pei-Pei Su; Dong-Wei Liu; Si-Jie Zhou; Hang Chen; Xian-Ming Wu; Zhang-Suo Liu
Journal:  Mil Med Res       Date:  2022-05-26

Review 3.  Mitophagy in depression: Pathophysiology and treatment targets.

Authors:  Ashutosh Tripathi; Giselli Scaini; Tatiana Barichello; João Quevedo; Anilkumar Pillai
Journal:  Mitochondrion       Date:  2021-08-31       Impact factor: 4.160

4.  Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation.

Authors:  Cui Ma; Xiaoying Wang; Siyu He; Lixin Zhang; June Bai; Lihui Qu; Jing Qi; Xiaodong Zheng; Xiangrui Zhu; Jian Mei; Xiaoyu Guan; Hao Yuan; Daling Zhu
Journal:  Cell Biosci       Date:  2022-01-28       Impact factor: 7.133

Review 5.  Emerging role of m6A methylation modification in ovarian cancer.

Authors:  Lin-Lin Chang; Xia-Qing Xu; Xue-Ling Liu; Qian-Qian Guo; Yan-Nan Fan; Bao-Xia He; Wen-Zhou Zhang
Journal:  Cancer Cell Int       Date:  2021-12-11       Impact factor: 5.722

6.  Vitamin B12 Attenuates Acute Pancreatitis by Suppressing Oxidative Stress and Improving Mitochondria Dysfunction via CBS/SIRT1 Pathway.

Authors:  Jiyan Yuan; Zeliang Wei; Guang Xin; Xubao Liu; Zongguang Zhou; Yi Zhang; Xiuxian Yu; Chengyu Wan; Qingqiu Chen; Weiyu Zhao; Xueling Wang; Yuman Dong; Zhen Chen; Xiaoting Chen; Hai Niu; Wen Huang
Journal:  Oxid Med Cell Longev       Date:  2021-12-09       Impact factor: 6.543

7.  Targeting Mitochondrial COX-2 Enhances Chemosensitivity via Drp1-Dependent Remodeling of Mitochondrial Dynamics in Hepatocellular Carcinoma.

Authors:  Lin Che; Jia-Shen Wu; Ze-Bang Du; Yu-Qiao He; Lei Yang; Jin-Xian Lin; Zhao Lei; Xiao-Xuan Chen; Dong-Bei Guo; Wen-Gang Li; Yu-Chun Lin; Zhong-Ning Lin
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639

Review 8.  Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.

Authors:  Milad Ashrafizadeh; Mahshid Deldar Abad Paskeh; Sepideh Mirzaei; Mohammad Hossein Gholami; Ali Zarrabi; Farid Hashemi; Kiavash Hushmandi; Mehrdad Hashemi; Noushin Nabavi; Francesco Crea; Jun Ren; Daniel J Klionsky; Alan Prem Kumar; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-03-22

9.  Elaiophylin Inhibits Tumorigenesis of Human Uveal Melanoma by Suppressing Mitophagy and Inducing Oxidative Stress via Modulating SIRT1/FoxO3a Signaling.

Authors:  Xue Zhu; Wenjun Zou; Xinmin Meng; Jiali Ji; Xun Wang; Hong Shu; Yuan Chen; Donghui Pan; Ke Wang; Fanfan Zhou
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

Review 10.  Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer.

Authors:  Antonino Colloca; Anna Balestrieri; Camilla Anastasio; Maria Luisa Balestrieri; Nunzia D'Onofrio
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.